The Lancet thelancet.com

[Series] Policies to halt and reverse the rise in ultra-processed food production, marketing, and consumption

thelancet.com·26w

[Series] Ultra-processed foods and human health: the main thesis and the evidence

thelancet.com·26w

[Health Policy] Lancet Countdown on health and climate change in Africa: an international collaboration for locally led research and action

thelancet.com·26w

[Articles] Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, doubl...

thelancet.com·26w

[Series] Towards unified global action on ultra-processed foods: understanding commercial determinants, countering corporate power, and mobilising a public heal...

thelancet.com·26w

[Comment] Methoxyflurane: a promising non-intravenous, non-opioid analgesic

thelancet.com·26w

[Articles] Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): resul...

thelancet.com·26w

[Health Policy] Lancet Countdown on health and climate change in Africa: an international collaboration for locally led research and action

thelancet.com·26w

[Articles] Comparison of inhalational methoxyflurane, intranasal fentanyl, and intravenous morphine for treatment of prehospital acute pain in Norway (PreMeFen)...

thelancet.com·26w

[Comment] Neoadjuvant quadruplet chemotherapy PAXG for pancreatic cancer

thelancet.com·26w

[Articles] Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): resul...

thelancet.com·26w

[Comment] Methoxyflurane: a promising non-intravenous, non-opioid analgesic

thelancet.com·26w

[Articles] Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, doubl...

thelancet.com·26w

[Comment] Protecting children from ultra-processed foods

thelancet.com·26w

[Correspondence] Catch-up growth after switch to asciminib in a twin with chronic myeloid leukaemia

thelancet.com·26w

[Comment] Global action on ultra-processed foods: a health, equity, and sustainability imperative

thelancet.com·26w

[Comment] Uniting academies of medicine on climate and health

thelancet.com·26w

[Series] Ultra-processed foods and human health: the main thesis and the evidence

thelancet.com·26w

[Series] Towards unified global action on ultra-processed foods: understanding commercial determinants, countering corporate power, and mobilising a public heal...

thelancet.com·26w

[Series] Policies to halt and reverse the rise in ultra-processed food production, marketing, and consumption

thelancet.com·26w

Log in to enable infinite scrolling